Filter by: patients
Home > Community Treatment Reports and Side Effects > Piribedil Treatment Report
What is Piribedil?

Piribedil is a piperazine dopamine agonist marketed as trivastal retard 50. It is used in the treatment of cognitive disorders associated with Parkinson's and other diseases, either alone (without L-dopa) or in combination with L-dopa therapy, in the early stages as well as in the advanced stages. Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 3 1 Efficacy_slight

See 1 patient currently taking Piribedil

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Dosages

  200 mg daily
  1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Piribedil (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 33%
Side effects too severe 1   Side effects too severe: 33%
Other 1   Other: 33%

See all 3 patients who’ve stopped taking Piribedil

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Piribedil

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Piribedil

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Piribedil

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Piribedil

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of Piribedil

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

Report created on February 11, 2012.